GB1158283A - Composition to be Applied to Skin and Process for Preparing Same. - Google Patents
Composition to be Applied to Skin and Process for Preparing Same.Info
- Publication number
- GB1158283A GB1158283A GB4455866D GB4455866D GB1158283A GB 1158283 A GB1158283 A GB 1158283A GB 4455866 D GB4455866 D GB 4455866D GB 4455866 D GB4455866 D GB 4455866D GB 1158283 A GB1158283 A GB 1158283A
- Authority
- GB
- United Kingdom
- Prior art keywords
- agent
- acid
- derivatives
- pharmaceutically acceptable
- coal tar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1,158,283. Compositions for topical application. FOSTER-MILBURN CO. 5 Oct., 1966 [21 Oct., 1965], No. 44558/66. Heading A5B. Compositions to be applied to the skin and having increased percutaneous absorption through and retention in skin comprise a stable, topically active chemical compound (e.g. an anti-acne agent, an anti-inflammatory agent, an anticholinergic, an emollient, a sex hormone, crude coal tar, an antipsoriatic agent or an antimetabolite) solubilized in a pharmaceutically acceptable vehicle having as one component an amide having the structural formula wherein R<SP>1</SP> is H or Me, R<SP>2</SP> is H or an alkyl radical containing not more than 2 carbon atoms, and R<SP>3</SP> is an alkyl radical containing not more than 2 carbon atoms. The amide is preferably N,N-dimethyl acetamide, N,N- dimethyl formamide or N,N-diethyl acetamide. The topically active chemical compound may be an anti-inflammatory agent, e.g. triamcinolone acetonide, fluocinolone acetonide, betamethasone valerate, flurandren alone acetonide and hydrocortisone, an anticholinergic e.g. hexopyrronium bromide, an antimetabolite e.g. 5-fluorouracil, 4-amino-n<SP>10</SP>-methylpteroylglutamic acid and b-mercaptopurine; an antimicrobial agent e.g. erythromycin, tetracyclines, chloromycetin, oleandomycin, chloramphenicol, 2,2'-methylenebis (3,4,6-trichlorophenol), 3,4',5-tribromosalicylanilide, 3,4,4'- trichlorocarbanilide, nystatin, undecylenic acid, sulphur, salicylic acid, parachlorometaxylenol, 2-(4'-thiazolyl)-benzimidazole, iodine, iodochlorhydroxyguin- and 5-iodo-2'-deoxyuridine, an emollient e.g. lanolin and lanolin alcohols and their ethoxylated and/or acetylated products, glycerol, glycols and their derivatives, fatty acids, their esters, alcohols and derivatives; a sex hormone e.g. testosterone and oestradial; a sunscreen agent e.g. para-aminobenzoic acid, amyl p-dimethylaminobenzoate, cinnamic acid and benzophenones and their derivatives and coal tar products including anthracene and a composition containing sulphur, salicylic acid, hexachlorophene and crude coal tar extract. The amides may be used alone or in combination with other additional pharmaceutically acceptable surface active agents, emulsifiers, solvents, vehicles or other pharmaceutically acceptable bases.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49933065A | 1965-10-21 | 1965-10-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1158283A true GB1158283A (en) | 1969-07-16 |
Family
ID=23984853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4455866D Expired GB1158283A (en) | 1965-10-21 | 1966-10-05 | Composition to be Applied to Skin and Process for Preparing Same. |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1158283A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2133690A (en) * | 1983-01-10 | 1984-08-01 | Young & Company Limited Robert | Percutaneous levamisole compositions |
FR2547503A1 (en) * | 1983-05-20 | 1984-12-21 | Nitto Electric Ind Co | NOVEL SOLVENT-AUXILIARY PENETRATION SYSTEM FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS BY PERCUTANEOUS ADMINISTRATION |
WO2008104532A1 (en) * | 2007-02-26 | 2008-09-04 | Galderma Research & Development | Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin |
US8466138B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US9125816B2 (en) | 2000-08-30 | 2015-09-08 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
-
1966
- 1966-10-05 GB GB4455866D patent/GB1158283A/en not_active Expired
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2133690A (en) * | 1983-01-10 | 1984-08-01 | Young & Company Limited Robert | Percutaneous levamisole compositions |
FR2547503A1 (en) * | 1983-05-20 | 1984-12-21 | Nitto Electric Ind Co | NOVEL SOLVENT-AUXILIARY PENETRATION SYSTEM FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE AGENTS BY PERCUTANEOUS ADMINISTRATION |
US9132089B2 (en) | 2000-08-30 | 2015-09-15 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
US9125816B2 (en) | 2000-08-30 | 2015-09-08 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
US8486925B2 (en) | 2005-10-12 | 2013-07-16 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8466137B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8466136B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8729057B2 (en) | 2005-10-12 | 2014-05-20 | Unimed Pharmaeuticals, LLC | Testosterone gel and method of use |
US8741881B2 (en) | 2005-10-12 | 2014-06-03 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8754070B2 (en) | 2005-10-12 | 2014-06-17 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8759329B2 (en) | 2005-10-12 | 2014-06-24 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8466138B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
WO2008104532A1 (en) * | 2007-02-26 | 2008-09-04 | Galderma Research & Development | Topical composition comprising fluocinolone acetonide for use in depigmentation of the skin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4323558A (en) | Topical trien containing pharmaceutical compositions and methods of use | |
US4557934A (en) | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one | |
US4954487A (en) | Penetrating topical pharmaceutical compositions | |
KR930007444A (en) | Pharmaceutical composition containing 4-biphenylacetic acid (BPAA) | |
US4130643A (en) | Dermatological compositions | |
US3952099A (en) | Dermatological compositions | |
US3592930A (en) | Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle | |
US10953021B2 (en) | Topical compositions of flunisolide and methods of treatment | |
DE3783683T2 (en) | SKIN PENETRATION-IMPROVING COMPOSITIONS. | |
US4150114A (en) | Dermatological compositions | |
US3749773A (en) | Gelled steroid ointment | |
KR100952786B1 (en) | Pharmaceutical composition | |
NZ197668A (en) | Composition for topical use containing a diol and a cell envelope-disordering compound | |
GB1593786A (en) | Pharmaceutical formulations | |
IE43655B1 (en) | Pharmaceutical composition | |
US4048310A (en) | Topical steroid formulation in form of lotion or cream | |
CA1139665A (en) | Corticosteroid formulations containing sebacate carrier | |
GB1158283A (en) | Composition to be Applied to Skin and Process for Preparing Same. | |
GB1349955A (en) | Dermatological composition | |
US3856954A (en) | Topical steroid compositions | |
US4473565A (en) | Topical anti-inflammatory drug therapy | |
IE41287L (en) | Steroid pharmaceutical composition | |
US3689667A (en) | C22 acid and its salts to promote wound healing | |
ES479691A1 (en) | Solid stable pharmaceutical composition on the basis of a 1,3-diester of 17-alpha-ethynyl-7-alpha-methyl-1,3,5(10)-estratriene-1,3,17-beta-triol. | |
IE39113B1 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] |